These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10904981)

  • 21. Tiagabine in clinical practice.
    Genton P; Guerrini R; Perucca E
    Epilepsia; 2001; 42 Suppl 3():42-5. PubMed ID: 11520322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term safety of tiagabine.
    Kälviäinen R
    Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician.
    Schmidt D; Gram L; Brodie M; Krämer G; Perucca E; Kälviäinen R; Elger CE
    Epilepsy Res; 2000 Oct; 41(3):245-51. PubMed ID: 10962215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient dystonias in three patients treated with tiagabine.
    Wolańczyk T; Grabowska-Grzyb A
    Epilepsia; 2001 Jul; 42(7):944-6. PubMed ID: 11488897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epilepsy in the elderly: the use of tiagabine.
    Pedersen B
    Epilepsia; 2001; 42 Suppl 3():52-4. PubMed ID: 11520325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment.
    Sackellares JC; Krauss G; Sommerville KW; Deaton R
    Epilepsia; 2002 Apr; 43(4):394-8. PubMed ID: 11952769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [GEOS (Gabitril Epilepsy Observational Study) -- Polish results of the international study of tiagabine in partial epilepsy].
    Niedzielska K
    Neurol Neurochir Pol; 2005; 39(6):459-65. PubMed ID: 16355303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment.
    Eckardt KM; Steinhoff BJ
    Epilepsia; 1998 Jun; 39(6):671-4. PubMed ID: 9637612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC; Noble S
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons.
    Shinnar S; Berg AT; Treiman DM; Hauser WA; Hesdorffer DC; Sackellares JC; Leppik I; Sillanpaa M; Sommerville KW
    Epilepsia; 2001 Mar; 42(3):372-9. PubMed ID: 11442155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International experience with tiagabine add-on therapy.
    Ben-Menachem E
    Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Status epilepticus and tiagabine therapy revisited.
    Koepp MJ; Edwards M; Collins J; Farrel F; Smith S
    Epilepsia; 2005 Oct; 46(10):1625-32. PubMed ID: 16190934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
    Chmielewska B; Stelmasiak Z
    Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tiagabine for epilepsy.
    Med Lett Drugs Ther; 1998 Apr; 40(1024):45-6. PubMed ID: 9580745
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-convulsive status epilepticus associated with tiagabine in a pediatric patient.
    Mangano S; Cusumano L; Fontana A
    Brain Dev; 2003 Oct; 25(7):518-21. PubMed ID: 13129597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerability of tiagabine: a prospective open-label study.
    Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
    Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Open study with tiagabine in partial epilepsy].
    Arroyo S
    Rev Neurol; 2000 Oct 16-31; 31(8):728-32. PubMed ID: 11082879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.
    Samara EE; Gustavson LE; El-Shourbagy T; Locke C; Granneman GR; Sommerville KW
    Epilepsia; 1998 Aug; 39(8):868-73. PubMed ID: 9701378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tiagabine exerts an anti-epileptogenic effect in amygdala kindling epileptogenesis in the rat.
    Dalby NO; Nielsen EB
    Neurosci Lett; 1997 Jun; 229(2):135-7. PubMed ID: 9223609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.